Journal of Research in Medical Sciences, 2012 Background: Postoperative nausea and vomiting are some of the important and common side effects of anesthesia after surgery occurring in almost 20-30% of patients and is the second factor of a patient′s complaint and inconvenience after pain.
Seyed M Lahsaei +3 more
doaj +2 more sources
Nausea and vomiting in pregnancy (NVP) is not just 'Morning Sickness' : data from a prospective cohort study [PDF]
, 2020 Background: Nausea and vomiting in pregnancy is usually called ‘morning sickness’. This is felt by sufferers to trivialise the condition. Symptoms have been described as occurring both before and after noon, but daily symptom patterns have not been ...
Gadsby, Roger +4 more
core +1 more source
Hyperemesis gravidarum: Associations with personal and family history of nausea
Acta Obstetricia et Gynecologica Scandinavica, 2023 Introduction The pathogenesis and risk factors for hyperemesis gravidarum, excessive nausea and vomiting of pregnancy, are not adequately recognized. In our previous study, we found that women with a personal history of nausea in different situations and
Venla S. Lindström +4 more
doaj +1 more source
Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study [PDF]
Korean Journal of Anesthesiology, 2023 Background Remimazolam is a novel ultrashort-acting benzodiazepine that has recently become available for general anesthesia. However, the incidence of postoperative nausea and vomiting (PONV) associated with remimazolam remains unknown.
Yuji Suzuki +4 more
doaj +1 more source
Supplemental prophylactic intervention for chemotherapy-induced nausea and emesis (spice) trial: Protocol for a multi-centre double-blind placebo-controlled randomized trial [PDF]
, 2018 Aim: There is significant recent interest in the role of ginger root (Zingiber officinale) as an adjuvant therapy for chemotherapy‐induced nausea. The supplemental prophylactic intervention for chemotherapy‐induced nausea and emesis (SPICE) trial aims
Bird, Robert +8 more
core +1 more source
Cancer Reports, 2022 Background Chemotherapy‐induced nausea and vomiting (CINV) is a major concern of patients with cancer, leading to suboptimal treatment. Aim This study assessed the emetic risk associated with intravenous and oral chemotherapy and the prophylactic ...
Ayako Okuyama +2 more
doaj +1 more source
Indian Journal of Medical and Paediatric Oncology, 2013 Background: Chemotherapy induced nausea and vomiting (CINV) is one of the most disturbing side-effects in children receiving highly emetogenic chemotherapy.
Suna Emir +2 more
doaj +1 more source
Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration [PDF]
, 2014 Cisplatin is a highly emetogenic cancer chemotherapy agent, which is often used to induce nausea and emesis in animal models. The cytotoxic properties of cisplatin also cause adverse events that negatively impact on animal welfare preventing repeated ...
A Tidholm +46 more
core +2 more sources
Chemotherapy-induced nausea and vomiting: A narrative review to inform dietetics practice [PDF]
, 2016 Chemotherapy-induced nausea and vomiting (CINV) are common nutrition-impact symptoms experienced by cancer patients. They exert a detrimental effect on dietary intake, risk of malnutrition and quality of life.
Isenring, Liz +4 more
core +3 more sources
Frequency of Predisposing Factor of Nausea and Vomiting After Chest Surgery Under General Anaesthesia [PDF]
, 2019 Background: Postoperative nausea and vomiting are common and distressing postsurgical symptoms. These symptoms are of particular concern in outpatient surgery because they may require additional direct resources, such as supplies and antiemetic ...
Bhatti, S. U. (Sami) +5 more
core +2 more sources